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Crush injury secondary to sjambok beatings is a well-described 
phenomenon in southern Africa. The sjambok, a type of traditional 
stiff whip normally made out of animal leather or plastic, is often 
used to inflict punishment in ‘community justice’ events. Damage to 
underlying muscle results in the release of myoglobin. Subsequent 
myoglobin deposition in the kidneys, combined with hypovolaemia 
from fluid sequestration into the damaged soft tissues and renal 
tubular cast formation, can result in acute kidney injury (AKI).
Risk stratification for prognostication in AKI has progressed from 
various consensus definitions, from the Risk, Injury, Failure, Loss 
and End-stage renal disease (RIFLE)[1] to the Acute Kidney Injury 
Network (AKIN)[2] and now the Kidney Disease Improving Global 
Outcomes (KDIGO) scoring system.[3] These systems use urine 
output, the glomerular filtration rate or serum creatinine for risk 
stratification.
Previous studies by Muckart et al.[4,5] described AKI following 
sjambok injuries and subsequently examined risk stratification in a 
cohort of 64 patients who presented to an acute care surgical unit, 
using serum venous bicarbonate (VB), serum electrolytes and urine 
pigment as biomarkers to predict severity of injury. Other studies 
have examined the use of serum creatine kinase (CK).[6,7]
Objective
To examine the use of VB in the modern era of risk stratification of 
AKI using the KDIGO scoring system and compare initial serum VB 
with the need for renal replacement therapy (RRT).
Methods
The primary objective was to compare the risk prediction score using 
VB for crush syndrome (as developed by Muckart et al.[5]) with the 
KDIGO scoring system for AKI in a cohort of patients presenting to 
a surgical unit after sjambok or punishment beatings. The endpoints 
were the need for RRT and mortality. The secondary objectives were 
to evaluate the utility of serum base excess (BE) and CK in predicting 
the need for RRT.
Data were collected from a database maintained by the Pieter-
maritzburg Metropolitan Trauma Service from June 2010 to 
December 2012. This database included patient admissions from 
Grey’s and Edendale hospitals in KwaZulu-Natal Province, South 
Africa (SA). Ethics application was made to the University of 
KwaZulu-Natal Biomedical Research Ethics Committee prior to 
establishment of the database (ref. no. BCA221/13), and patient 
confidentiality was maintained.
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Background. Crush injury secondary to sjambok beatings is a well-described phenomenon in southern Africa. Owing to a number of 
factors, it can result in acute kidney injury (AKI). In 1992, Muckart et al. described a risk stratification system using venous bicarbonate 
(VB) that can be used in the management of these patients.
Objective. To validate this score in the modern era of AKI risk stratification.
Methods. A retrospective study was performed on a local trauma database from June 2010 to December 2012. All patients with crush 
injury from sjambok/blunt instrument beatings were included in the analysis. VB was compared with the Kidney Disease Improving Global 
Outcomes scoring system for AKI. Serum base excess (BE) and creatine kinase were also examined as biomarkers. The endpoints were the 
need for renal replacement therapy (RRT) and mortality.
Results. Three hundred and ten patients were included. The overall mortality rate was 1.9%, 14.8% of patients had AKI, and 3.9% required 
RRT. Both VB and BE performed well in RRT prediction, with areas under the receiver operating characteristic curve of 0.847 (95% confidence 
interval (CI) 0.756 - 0.938; p<0.001) and 0.871 (95% CI 0.795 - 0.947; p<0.001), respectively. The sensitivity and specificity of BE were 83.3% 
and 80.2% at an optimal cut-point of –7.25 mmol/L, while those of VB were 83.3% and 79.5% at an optimal cut-point of 18.85 mmol/L. VB 
was significantly different across the AKI risk groups (p<0.001), in keeping with the original Muckart risk stratification system.
Conclusion. The risk stratification score using VB is valid and should continue to be used as a tool in the management of patients with 
sjambok injuries. BE performs well in predicting the need for RRT, with a value of <–7.25 mmol/L indicating severe injury.
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All patients in the database with a diagnosis of sjambok injury or crush 
injury were included in the analysis. Patients with crush injury and 
complex multisystem trauma were excluded from the study. Patient 
demographics were extracted, along with the admission blood results. 
Urinary pigment was checked by either a urinary dipstick reacting to 
haemoglobin or formal urinary myoglobin measurement. RRT was 
either peritoneal dialysis or haemodialysis, as resources dictated.
The previously validated score of risk stratification as per the 
original article by Muckart et al.[5] involved the use of urine pigment, 
VB and serum electrolytes (Table 1).
We planned to assess the validity of VB as proposed in the original 
article[5] by comparing the three groups of VB, namely >20 mmol/L, 
17 - 20 mmol/L and <17 mmol/L. The injury severity of ‘minimal’ 
was omitted, and we did not examine urine pigment or serum 
electrolytes as risk-stratifying biomarkers.
AKI was diagnosed and staged via the highest serum creatinine 
measurement as per the KDIGO system (Table 2).[3] As no 
patients were admitted with a known baseline creatinine level, the 
Modification of Disease in Renal Diet equation was used to calculate 
an assumed baseline (using age, sex and race), as per the KDIGO 
recommendations.[3]
Statistical analysis
Continuous data were reported as means and standard deviations 
(SDs) or medians and interquartile ranges (IQRs), as appropriate. 
The χ2 test with continuity correction was used for categorical data, 
and Student’s t-test or the Mann-Whitney U-test for continuous data 
where appropriate.
Receiver operating characteristic (ROC) curves were constructed 
for VB, CK and BE to examine their sensitivity and specificity v. 
the need for RRT. The area under the curve (AUC), 95% confidence 
intervals (CIs) and optimal cut-points were reported for all three 
biomarkers.
All p-values were reported to three decimal places, and statistical 
significance was defined as a two-sided p-value <0.05. All data analyses 
were performed using SPSS 24.0 for Macintosh (IBM Corp., USA).
Results
Three hundred and ten patients were admitted to the surgical units 
with a crush injury from sjambok or blunt instrument beatings. The 
majority were male (83.3%) and young (mean (SD) age 27  (9.8) 
Table 2. KDIGO risk stratification for AKI
KDIGO Serum creatinine Urine output
Stage 1 ↑ in serum creatinine to ≥26.5 




Stage 2 ↑ in serum creatinine to 200 - 
299% (>2 - 2.9-fold) from baseline
<0.5 mL/kg/h 
≥12 h
Stage 3 ↑ in serum creatinine to ≥300% 
(≥3-fold) from baseline or




≥24 h or anuria 
≥12 h









Minimal >20 Normal Negative
Mild >20 Normal Positive
Moderate 17 - 20 Normal Positive
Major 17 - 20 Abnormal Positive
Massive <17 Abnormal Positive 
Table 3. Demographics and outcomes of patients admitted 




(n=264) AKI (n=46) p-value
Male, n (%) 258 (81.9) 220 (83.3) 35 (14.8) 0.235
Age (yr), mean 
(SD)
27.0 (9.8) 26.4 (8.9) 30.6 (13.2) <0.001
Mortality, n (%) 6 (1.9) 1 (0.4) 4 (8.7) 0.002
RRT, n (%) 12 (3.9) 0 (0) 12 (26.1) <0.001
Table 4. Admission serum biochemical values of patients presenting with sjambok injuries* 
All patients (N=310) No AKI (n=264) AKI (n=46) p-value
pH, median (IQR) 7.36 (7.30 - 7.39) 7.36 (7.31 - 7.40) 7.30 (7.21 - 7.37) 0.001
Lactate (mmol/L), median (IQR) 3.1 (1.8 - 4.5) 3.1 (1.7 - 4.3) 3.8 (1.9 - 8.0) 0.114
PaCO2 (kPa), median (IQR) 5.2 (4.7 - 5.9) 5.3 (4.7 - 5.9) 5.1 (3.9 - 5.6) 0.027
Bicarbonate (mmol/L), median (IQR) 21.4 (19.0 - 24.0) 22.0 (20.0 - 24.0) 16.8 (14.0 – 20.0) <0.001
BE (mmol/L), median IQR) –3.9 (–7.0 - –1.6) –3.5 (–6.4 - –1.3) –10.2 (–12.6 - –5.7) <0.001
Hb (g/dL), median (IQR) 13.4 (11.3 - 14.7) 13.6 (12.2 - 13.9) 10.4 (8.1 - 13.7) <0.001
Sodium (mmol/L), median (IQR) 138 (135 - 140) 138 (135 - 140) 135 (133 - 138) <0.001
Potassium (mmol/L), median (IQR) 4.1 (3.8 - 4.5) 4.1 (3.8 - 4.4) 4.3 (3.9 - 5.0) 0.006
Chloride (mmol/L), median (IQR) 106 (102 - 108) 106 (103 - 108) 106 (100 - 109) 0.653
Urea (mmol/L), median (IQR) 4.1 (3.1 - 5.8) 3.9 (3.9 - 5.0) 9.3 (5.8 - 20.7) <0.001
Creatinine (µmol/L), median (IQR) 83 (70 - 110) 81 (68 - 93) 196 (153 - 423) <0.001
Corrected calcium (mmol/L), median (IQR) 2.28 (2.18 - 2.34) 2.28 (2.20 - 2.34) 2.18 (2.06 - 2.29) 0.011
Magnesium (mmol/L), median (IQR) 0.81 (0.71 - 0.91) 0.81 (0.73 - 0.90) 0.76 (0.69 - 0.91) 0.692
Phosphate (mmol/L), median (IQR) 1.18 (0.98 - 1.49) 1.15 (0.93 - 1.46) 1.48 (1.17 - 1.85) 0.001
CK (U/L), median (IQR) 1 777 (602 - 3 981) 1 669 (595 - 3 207) 3 527 (961 - 7 534) 0.015
Urinary pigment present, n (%) 186 (60.0) 150 (56.8) 36 (78.3) 0.010
PaCO2 = partial pressure of arterial carbon dioxide; Hb = haemoglobin.*Data incomplete for CK (52.9% missing), phosphate (52.3%), calcium (59.7%) and magnesium (51.9%), as these are not considered routine screening tests in patients with crush injury.
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years). There was a low mortality rate of 1.9% (n=6 patients). 
Forty-six patients (14.8%) were diagnosed with AKI and 12 (3.9%) 
required RRT (Table 3). The results of biochemical investigations on 
admission are set out in Table 4.
Of patients who presented with AKI, 18 had grade 1, 2 grade 2 and 
26 grade 3 AKI. Owing to the small number of patients with grade 2 
AKI, a post hoc decision was taken to combine this group with the 
grade 3 AKI group for the purposes of analysis. These groups were 
reported as no AKI, low-grade AKI (KDIGO stage 1) and high-grade 
AKI (KDIGO stages 2 and 3).
Serum CK levels were available for only 149 patients in the cohort, 
with a higher serum CK level in patients who developed AKI (median 
3 527 U/L) (IQR 961 - 7 925)) than in those who did not (1 777 U/L 
(IQR 602 - 3 981)) (p=0.015). Urinary pigment was present in a total 
of 186 patients (60.0%), and in 36 (78.3%) of those who developed 
AKI (p=0.010).
VB had an AUC for RRT of 0.847 (95% CI 0.756 - 0.938; p<0.001) 
(Fig. 1), CK an AUC of 0.722 (95% CI 0.544 - 0.900; p=0.026) (Fig. 2) 
and BE an AUC of 0.871 (95% CI 0.795 - 0.947; p<0.001) (Fig. 3). 
Table 5 indicates the optimal cut-points, sensitivity and specificity of 
the ROC curves for the three serum biomarkers.
Patients who received RRT had significantly lower VB than 
those who did not (16.5 mmol/L (IQR 13.4 - 18.6) v. 21.6 mmol/L 
(IQR 19.2 - 24.0) (p<0.001)). The median highest serum creatinine 
level in patients who received RRT was 358 µmol/L (IQR 224 - 603), 
and the median urea level was 18.1 mmol/L (IQR 8.9 - 22.8).
To validate the score developed by Muckart et al.,[5] patients were 
classified as mild, moderate or severe according to their VB only. 
Urine pigment and serum electrolytes were not included in the 








































Fig. 1. VB v. RRT receiver operator characteristic curve. Diagonal segments 
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Fig. 2. CK v. RRT receiver operator characteristic curve. Diagonal segments 
are produced by ties.
Fig. 3. BE v. RRT receiver operator characteristic curve. Diagonal segments 








































Table 5. Performance of serum biomarkers for predicting the 
need for RRT
Optimal cut-point Sensitivity, % Specificity, %
BE –7.25 mmol/L 83.3 80.2
VB 18.85 mmol/L 83.3 79.5
CK 2 791 mmol/L 77.8 67.9
Table 6. Muckart score applied to the sjambok patient cohort (N=310)
Mild (VB >20 mmol/L, 
n=192)
Moderate (VB 17 - 20 
mmol/L, n=74)
Severe (VB <17 mmol/L, 
n=44) p-value
VB (mmol/L), median (IQR) 23.0 (21.9 - 24.7) 19.1 (18.0 - 20.0) 14.3 (13.0 - 16.0)
Serum creatinine (µmol/L), median (IQR) 81 (69 - 93) 84 (74 - 127) 162 (103 - 557) <0.001
BE (mmol/L), median (IQR) –2.2 (–3.9 - –0.3) –6.5 (–7.4 - –5.3) –12.1 (–14.2 - –10.8) <0.001
CK (mmol/L), median (IQR) 1738 (602 - 3 207) 1 721 (708 - 5 592) 3 991 (671 - 7 543) 0.204
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across the three groups (p<0.001), while CK was not significantly 
different (p=0.204) (Table 6). Patients were also classified according 
to their KDIGO staging, and VB and BE remained significant 
(p<0.001) while CK did not (p=0.052) (Table 7).
Discussion
This study confirms that VB remains a valid risk stratification tool in 
the management of patients at risk of AKI from crush injury. We have 
also shown that BE performs well as a biomarker for prediction of the 
need for RRT. Although CK is associated with the need for RRT, its 
performance is poorer than that of VB or BE, and importantly, the 
CK level does not discriminate between low-grade and high-grade 
AKI. This therefore precludes the use of CK as a risk stratification 
tool for AKI following crush injury. Other authors have reported 
similar findings.[7-9] Serum CK may be useful for the diagnosis of 
crush injury, rather than for risk stratification.
The mortality rate in our study was low (8.7%). In our previous 
study examining AKI in critically ill patients,[10] we noted a low 
mortality rate among critically ill patients with sjambok injuries 
(23%), albeit in a small cohort of 13 patients. These findings contrast 
with other forms of trauma-associated AKI, where authors have 
reported mortality rates ranging from 28% to 100%.[11-13] Other 
studies examining mortality from all causes of rhabdomyolysis report 
rates of 5 - 24%.[6,8,14]
Study strengths and limitations
The strength of this study is that it examined a large, homogeneous 
population group over a 2-year period. Follow-up was complete to 
patient discharge. Although this study was performed in surgical 
units in KwaZulu-Natal, we believe that our findings are applicable 
to patients with crush syndrome in other surgical and emergency 
medicine units across SA.
There are some limitations to this study. There were no data avail-
able regarding the type, timing and volume of fluid administration 
prior to the serum samples being drawn, which could potentially 
have altered the biochemistry results. The period of time between the 
injury and presentation to a health facility was also unknown. Study 
data were also incomplete for serum CK (52.9% missing), phosphate 
(52.3%), calcium (59.7%) and magnesium (51.9%), as these are not 
considered routine screening tests in patients with crush injury.
Indications for RRT, types of RRT and triggers for RRT were not 
standardised in this study. This may have led to variability in the 
prescription and use of RRT.
Recommendations
We recommend that clinicians involved in the care of patients with 
crush injury from sjambok beating adopt the system we propose of 
early risk stratification using the initial VB, without the need for 
urine dipstick analysis or serum electrolyte analysis, based on the VB 
categories shown in Table 6.
In our resource-constrained environment, other renal biomarkers, 
such as urinary neutrophil gelatinase-associated lipocalin/cystatin C 
or kidney injury molecule 1, are currently too expensive to be used 
routinely. VB is a cost-effective tool for risk stratification in this 
setting.
We also recommend that patients presenting with a BE <–7.25 
mmol/L in combination with a VB of <17 mmol/L be managed 
in a healthcare facility that has access to adequate monitoring of 
renal function and access to RRT, as these patients have a high risk 
of needing RRT. Rapid access to RRT is lifesaving in patients who 
present with severe-grade sjambok injury and established AKI that is 
not responsive to intravenous fluid therapy
We hypothesise that the form of AKI in sjambok injuries is 
associated with an aerobic acidosis, while other forms of AKI in 
trauma are due to anaerobic conditions such as anaemia, hypotension 
and reperfusion, all of which have significant systemic effects, leading 
to multiple organ dysfunction. Supporting this hypothesis is the 
finding that all the patients presented with very mild lactate elevation 
(a marker of anaerobic metabolism), with no difference between 
patients with or without AKI. Future studies should be aimed at 
investigating this hypothesis.
Studies are also required to examine the outcomes of patients who 
develop high-grade AKI requiring RRT and compare them with 
other forms of trauma-induced AKI requiring RRT. The role of early 
dialysis in this form of injury also requires investigation.
Conclusion
The risk stratification score using VB proposed by Muckart et 
al.[5] was shown to be valid in this study using the KDIGO risk 
stratification system, and can be simplified to use VB alone for risk 
stratification in the management of patients with sjambok injuries. 
BE performs well in predicting the need for RRT, with a value of 
<–7.25 mmol/L indicating severe injury.
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